C. Francis

发表

Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin*

S. Totterman, V. Marder, V. Pellegrini, 1997, Journal of Bone and Joint Surgery. American volume.

Venous Thrombosis and Stenosis After Implantation of Pacemakers and Defibrillators

J. Daubert, Burr Hall, S. Rosero, 2005, Journal of Interventional Cardiac Electrophysiology.

Outcomes after platelet transfusion in patients with heparin‐induced thrombocytopenia

M. Menegus, N. Blumberg, M. Refaai, 2010, Journal of thrombosis and haemostasis : JTH.

Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin*

A. Sahni, T. Odrljin, Abha Sahni, 1998, The Journal of Biological Chemistry.

Fibrinogen and Fibrin Protect Fibroblast Growth Factor-2 from Proteolytic Degradation

A. Sahni, C. Francis, L. A. Sporn, 2000, Thrombosis and Haemostasis.

Thrombin Activity Associated with Indwelling Central Venous Catheters

C. Francis, A. Felcher, J. Braaten, 1997, Thrombosis and Haemostasis.

A Soluble Fibrin Standard: Comparable Dose-response with Immunologic and Functional Assays

C. Francis, V. Marder, B. McCarron, 1999, Thrombosis and Haemostasis.

Transport Processes in Fibrinolysis and Fibrinolytic Therapy

C W Francis, A. Blinc, A Blinc, 1996, Thrombosis and Haemostasis.

Ultrasound Increases Flow through Fibrin Gels

C. Francis, A. Blinc, Julie V. Braaten, 1995, Thrombosis and Haemostasis.

A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma

P. T. Onundarson, E. Hawes, R. Gosselin, 2016, Journal of thrombosis and haemostasis : JTH.

Improving clinical practice guidelines for practicing cardiologists.

A. Moss, W. Zareba, R. Krone, 2015, The American journal of cardiology.

Structural Studies On The Functional Heterogeneity Of Von Willebrand Protein Polymers

C. Francis, V. Marder, G. Barlow, 1981 .

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

C. Francis, S. Goldhaber, T. Ortel, 2015, Journal of thrombosis and haemostasis : JTH.

Magnetic Resonance Imaging of Deep Vein Thrombi Correlates with Response to Thrombolytic Therapy

C. Francis, S. Totterman, C. Francis, 1995, Thrombosis and Haemostasis.

Plasminogen Depletion during Streptokinase Treatment or Two-Chain Urokinase Incubation Correlates with Decreased Clot Lysability Ex Vivo and In Vitro

V. Marder, C. Francis, P. Önundarson, 1993, Thrombosis and Haemostasis.

Prothrombotic Changes in Hemostatic Parameters and C-reactive Protein in the Elderly with Winter Acute Respiratory Tract Infections

A. Falsey, J. Kolassa, Brian Smith, 2001, Thrombosis and Haemostasis.

Anticardiolipin Antibodies and Recurrent Coronary Events: A Prospective Study of 1150 Patients

A. Moss, C. Francis, W. Zareba, 2000, Circulation.

On The Conversion Of High Molecular Weight Urokinase To The Low Molecular Weight Form

C. Francis, V. Marder, G. Barlow, 1981, Thrombosis and Haemostasis.

Fiix‐prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix‐warfarin or direct oral anticoagulants to standard PT‐warfarin

P. T. Onundarson, D. Arnar, C. Francis, 2016, International journal of laboratory hematology.

Comparison of Two Warfarin Regimens in the Prevention of Venous Thrombosis following Total Knee Replacement

C. Francis, S. Totterman, V. Marder, 1996, Thrombosis and Haemostasis.

Markers of Hemostatic Activation in Affected Coronary Arteries during Angioplasty

C. Francis, M. Cunningham, R. Pomerantz, 1994, Thrombosis and Haemostasis.

During warfarin induction, the Fiix‐prothrombin time reflects the anticoagulation level better than the standard prothrombin time

P. T. Onundarson, C. Francis, S. Júlíusson, 2017, Journal of thrombosis and haemostasis : JTH.

Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2*

A. Sahni, C. Francis, L. Sporn, 1999, The Journal of Biological Chemistry.

The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization.

K. Mann, J. Queenan, M. Gissel, 2009, Thrombosis research.

Evaluation of Platelet Activation, Fibrinolysis, and Hemostatic Activation During High Dose Dobutamine Stress Echocardiography

M. Winniford, J. Rossen, N. Shammas, 2003 .

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

A. Khorana, O. Hyrien, N. Mackman, 2008, Journal of thrombosis and haemostasis : JTH.

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

A. Khorana, G. Lyman, N. Kuderer, 2007, Journal of thrombosis and haemostasis : JTH.

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

R. Green, J. Deweese, C. Francis, 1994, Journal of vascular surgery.

Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement.

C. Francis, S. Totterman, V. Marder, 1992, JAMA.

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.

C. Francis, B. Eriksson, J. Caprini, 2010, Thrombosis research.

Fibrinogen binding potentiates FGF‐2 but not VEGF induced expression of u‐PA, u‐PAR, and PAI‐1 in endothelial cells

A. Sahni, C. Francis, P. Simpson‐Haidaris, 2004, Journal of thrombosis and haemostasis : JTH.

Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.

A. Sahni, C. Francis, C. Francis, 2000, Blood.

The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects

C. Francis, D. Springer, G. Lehmann, 2007, PPAR research.

Senior academic physicians and retirement considerations.

A. Moss, W. Zareba, R. Krone, 2013, Progress in cardiovascular diseases.

Effects of lipids and lipid‐lowering therapy on hemostatic factors in patients with myocardial infarction

A. Moss, C. Francis, W. Zareba, 2004, Journal of thrombosis and haemostasis : JTH.

FGF‐2 but not FGF‐1 binds fibrin and supports prolonged endothelial cell growth

A. Sahni, O. Altland, C. Francis, 2003, Journal of thrombosis and haemostasis : JTH.

Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor‐2 (FGF‐2)

A. Sahni, C. Francis, P. Simpson‐Haidaris, 2007, Journal of thrombosis and haemostasis : JTH.

15‐deoxy‐Δ12,14 prostaglandin J2‐induced heme oxygenase‐1 in megakaryocytes regulates thrombopoiesis

C. Baglole, N. Blumberg, R. Phipps, 2009, Journal of thrombosis and haemostasis : JTH.

Plasmic degradation modulates activity of fibrinogen‐bound fibroblast growth factor‐2

A. Sahni, C. Francis, C. Francis, 2003, Journal of thrombosis and haemostasis : JTH.

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots.

C. Francis, C W Francis, A. Blinc, 1995, Ultrasound in medicine & biology.

Anticardiolipin Antibodies and Recurrent Coronary Events: A Prospective Study of 1150 Patients

A. Moss, W. Zareba, L. Watelet, 2000, Circulation.

Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.

C. Francis, S. Totterman, V. Marder, 1990, Circulation.

Angioedema during therapy with recombinant tissue plasminogen activator.

B. Brenner, C. Francis, V. Marder, 1991, British journal of haematology.

Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form

Min Guo, S. Sahni, C. Francis, 2004 .